Marshall Wace LLP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Marshall Wace LLP
CRD #136854
SEC #801-65040
CIK #0001318757
AUM
Employees
Phone442073162250
AddressThe Adelphi Building, 111 John Adam St
London, United Kingdom
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($BB)
7.56.04.53.01.50.02004200920152021
CIK Period
0001318757
/
Sector Form 13F Holdings Cap ($BB) Value ($BB)
Zoetis 41.1 0.4
Amazon 733.6 0.3
Alphabet Google 706.6 0.3
Teleflex 11.9 0.3
Microsoft 747.7 0.2
Agilent Technologies 21.5 0.2
Thermo Fisher Scientific 90.1 0.2
Alibaba 355.3 0.2
Charles River 5.4 0.2
Transunion 10.5 0.2
Biohaven Pharmaceutical 1.6 0.2
New Senior Investment Group 0.3 0.1
Repligen 2.2 0.1
T-Mobile 55.2 0.1
Monster Beverage 26.5 0.1
Guardant Health 2.9 0.1
Home Depot 194.1 0.1
Tractor Supply 9.8 0.1
Fidelity National Information Services 33.6 0.1
Mastercard 209.2 0.1
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold ($MM) AUM ($MM)
Other Marshall Wace UCITS Funds PLC - MW ESG Market Neutral TOPS UCITS Fund 2020-07-24 2,325.9
HF Marshall Wace Common Contractual Fund - Mwccf World TOPS 150/50 Fund 2020-05-28 0.0
HF Marshall Wace Funds LP - MW TOPS Emerging Markets US Fund [2020-05-28] 950.0 127.6
HF Marshall Wace Investment Strategies - TOPS Global Equities LE Fund 2020-05-28 462.3
HF Marshall Wace Managed Accounts ICAV - MW TOPS Global Equities LE Fund [2020-05-28] 380.0 300.7
HF Marshall Wace Funds PLC - MW TOPS Emerging Markets Absolute Return Fund 2020-03-06 81.1
HF Marshall Wace Investment Strategies - TOPS Developed World Equities Fund 2020-03-06 399.4
HF Marshall Wace Investment Strategies - TOPS EM Equities Fund 2020-03-06 540.4
HF Marshall Wace Investment Strategies - TOPS Emerging Markets Absolute Return Fund 2020-03-06 281.3
HF Marshall Wace Managed Accounts ICAV - MW TOPS Developed World Equities Fund 2020-03-06 244.1
View All
Form D Directors # Filings # Firms 2011 - 2021
Vijayabalan Murugesu 114
Linburgh Martin 166
Ronan Daly 163
David Sargison 66
Barbara Healy 20
Robert Bovet 67
Barry McGrath 36
David Hammond 56
Marshall Wace LLP 42
Marshall Wace GP1 Ltd 17
EDGAR Form CIK 2011 - 2021
13F-HR [0001318757]
13F-NT [0001318757]
SC 13G [0001318757]
Form 13D/13G Filer Form 13D/13G Subject Filed
Marshall Wace LLP Esperion Therapeutics Inc [2020-06-15]
Terms | Privacy | Guide
tony@aum13f.com